Milestone Pharmaceuticals Inc.
General ticker "MIST" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $128.1M (TTM average)
Milestone Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 19.4%.
Estimated limits based on current volatility of 3.2%: low 1.33$, high 1.42$
Factors to consider:
- Total employees count: 33 as of 2024
- Top business risk factors: Regulatory and compliance, Manufacturing risks, Cybersecurity threats, Operational and conduct risks, Growth challenges
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.38$, 3.30$]
- 2026-12-31 to 2027-12-31 estimated range: [1.35$, 3.24$]
Financial Metrics affecting the MIST estimates:
- Positive: with PPE of -2.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 6.52 > -0.60
- Positive: 19.24 < Shareholder equity ratio, % of 36.78 <= 42.59
- Negative: negative Net income
Short-term MIST quotes
Long-term MIST plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.00MM | $0.00MM | $1.55MM |
| Operating Expenses | $62.10MM | $42.10MM | $63.69MM |
| Operating Income | $-61.10MM | $-42.10MM | $-62.14MM |
| Non-Operating Income | $1.41MM | $0.58MM | $-0.92MM |
| Interest Expense | $2.55MM | $3.58MM | $3.84MM |
| R&D Expense | $31.05MM | $14.36MM | $18.11MM |
| Income(Loss) | $-59.69MM | $-41.52MM | $-63.06MM |
| Net Income(Loss)* | $-59.69MM | $-41.52MM | $-63.06MM |
| Stockholders Equity | $16.77MM | $13.15MM | $41.77MM |
| Inventory | $0.00MM | $0.00MM | $0.65MM |
| Assets | $75.23MM | $75.50MM | $113.56MM |
| Operating Cash Flow | $-46.42MM | $-28.85MM | $-49.04MM |
| Capital expenditure | $0.11MM | $0.03MM | $0.30MM |
| Investing Cash Flow | $4.76MM | $8.28MM | $11.25MM |
| Financing Cash Flow | $47.79MM | $32.12MM | $85.53MM |
| Earnings Per Share** | $-1.39 | $-0.67 | $-0.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.